2005
DOI: 10.1016/j.jhep.2005.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
129
0
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 149 publications
(140 citation statements)
references
References 32 publications
(54 reference statements)
10
129
0
1
Order By: Relevance
“…Previous studies demonstrated that up-regulation of FZD7 was associated with activation of Wnt/β-catenin cascade in HCC [16,17]. The present study suggests that Wnt3 also has a positive effect on canonical Wnt signaling in HCC.…”
Section: Activation Of Wnt/β-catenin Signaling By Wnt3 Was Mediated Tsupporting
confidence: 68%
See 1 more Smart Citation
“…Previous studies demonstrated that up-regulation of FZD7 was associated with activation of Wnt/β-catenin cascade in HCC [16,17]. The present study suggests that Wnt3 also has a positive effect on canonical Wnt signaling in HCC.…”
Section: Activation Of Wnt/β-catenin Signaling By Wnt3 Was Mediated Tsupporting
confidence: 68%
“…In addition, overexpression of FZD7 was observed not only in tumors but also in matched surrounding dysplastic liver tissues. These observations suggest that it may be an early event during the development of this disease [16,17]. However, there is no information on which Wnt ligand(s) are involved in binding to FZD7 and result in subsequent activation of the Wnt/β-catenin pathway during tumor development.…”
Section: Introductionmentioning
confidence: 99%
“…Sustained activation of the canonical Wnt pathway due to mutational deregulation of Wnt cascade components, such as APC, axin or b-catenin, is associated with several cancers (Lustig and Behrens, 2003;Gregorieff et al, 2005). Moreover, abnormal activation of the Wnt signalling pathway could be independent of Wnt component mutations (Bafico et al, 2004;Merle et al, 2005). Recently Liu et al (2008) described activation of the pathway in the absence of activating mutations in NB cell lines and primary NBs.…”
Section: Discussionmentioning
confidence: 99%
“…In a majority of tumours, aberrant activation of the Wnt/b-catenin is the consequence of APC, Axin or b-catenin gene mutations (Lustig and Behrens, 2003). Moreover, it has been shown that overactivation of the Wnt signalling pathway is due to the overexpression of different FZD receptors in a variety of cancers (Milovanovic et al, 2004;Merle et al, 2005;Ueno et al, 2008). In NB, b-catenin has been shown to be strongly expressed and aberrantly localized in the nucleus in highly aggressive NB cells without MYCN amplification, whereas no b-catenin-specific mutations were identified (Liu et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the results suggest that multiple FZD/LRP-receptor complexes transducing canonical Wnt signalling could be formed and modulated by inhibitory molecules such as Dkk family members. In first trimester villous cytotrophoblasts canonical Wnt signalling, which is thought to be regulated by specific Wnt-FZD combinations [21], may involve putative ligand-receptor pairs of Wnt-1, Wnt-2, Wnt-2b, Wnt-7a, Wnt-7b, Wnt-9b, Wnt-10a, Wnt-10b with FZD1, FZD5, FZD7 or FZD10 [21][22][23][24][25]. It is likely that complexes of these proteins with LRP-6 control cytotrophoblast proliferation of early pregnancy in an autocrine manner since inhibition of the canonical Wnt pathway by Dkk-1 decreased basal cell growth in vitro [15].…”
Section: Discussionmentioning
confidence: 99%